RecruitingNot Applicable

Protective Effect of Early High Dose stATins On Cardiovascular and Renal Events in Acute Coronary Syndrome

Italy2,500 participantsStarted 2016-12-01

Plain-language summary

Registration of all ACS patients (STEMI and NSTEMI) admitted to the cardiology ward and scheduled for early invasive strategy. The aim is to evaluate the protective effects of early (on admission) high-dose high-potency statin therapy on early and mid-term cardiac and renal events in this subset of patients.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Acute coronary syndrome (ST elevation and non ST elevation) * Early invasive strategy Exclusion Criteria: * contraindication to statin therapy * refusal of consent

What they're measuring

Acute renal function changes

Timeframe: Within 72 hours after hospital admission

Inflammatory profile changes

Timeframe: up to 1 month

Lipid profile changes

Timeframe: up to 1 month

Platelet count

Timeframe: up to 1 month

Platelet volume

Timeframe: up to 1 month

Platelet aggregation profile

Timeframe: up to 1 month

Trial details

NCT IDNCT04087200

SponsorCentro Cardiopatici Toscani

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12-01

Contact for this trial

Anna Toso, MD

00393387982507 anna.toso@libero.it

View on ClinicalTrials.gov More Acute Coronary Syndrome trials